Non-nucleoside reverse transcriptase inhibitors
Lamivudine, Nevirapine, and Stavudine
Composition
- Active ingredients
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; STAVUDINE 30MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA200244.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine, Nevirapine, and Stavudine
- Active substance
- lamivudine
- Drug class
- Non-nucleoside reverse transcriptase inhibitors, Nucleoside and nucleotide reverse transcriptase inhibitors
- Group
- Antivirals
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Hetero Drugs LTD
- Status